<p>Moolec Science SA（&#34;Moolec&#34;或&#34;公司&#34;）收到了纳斯达克证券市场有限责任公司（&#34;纳斯达克&#34;）上市资格部门的额外决定函（&#34;函件&#34;），指出公司目前未满足纳斯达克上市规则 5550(b)(1) 下 250 万美元的最低股东权益要求。</p>
<p>正如公司在截至 2025 年 6 月 30 日的 20-F 表格中所披露的，管理层预计通过确认与某些子公司破产程序相关的约 1.058 亿美元的预估收益，重新符合纳斯达克持续上市标准。在完成这一会计过程后，公司预计该会计过程产生的收益将产生正的净收入，使公司能够满足纳斯达克 50 万美元的净收入标准要求。</p>
<p>在某些子公司申请破产后，去确认过程已经开始。</p>
<p>此披露是根据纳斯达克上市规则 5810(b) 进行的，该规则要求在收到不合规通知后及时进行公开公告。</p>
<p><strong>关于 Moolec Science SA</strong></p>
<p>Moolec Science 是一家以创新为驱动的公司，致力于工程植物和微生物，以解锁全球食品系统的可扩展蛋白质解决方案。通过整合分子农业和精密发酵，Moolec 将作物的成本效益与动物蛋白的功能性和营养结合起来，创造可持续且商业上可行的成分。公司的多元化产品线包括替代蛋白质、生物活性化合物、营养油和用于再生农业的生物输入。Moolec 拥有强大的知识产权组合，在多个技术平台上拥有超过 118 项已授予和待审专利。Moolec 的业务遍及美国、欧洲和南美，正在推进一种从种子到成分的方式，旨在改变未来的食品生产。Moolec 在纳斯达克上市，股票代码为&#34;MLEC&#34;。有关更多信息，请访问 www.moolecscience.com 和 ir.moolecscience.com。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿包含&#34;前瞻性声明&#34;。前瞻性声明可以通过使用诸如&#34;预测&#34;、&#34;打算&#34;、&#34;寻求&#34;、&#34;目标&#34;、&#34;预期&#34;、&#34;相信&#34;、&#34;期待&#34;、&#34;估计&#34;、&#34;计划&#34;、&#34;展望&#34;和&#34;项目&#34;等词语以及其他类似表达来识别，这些词语预测或指示未来事件或趋势，或不是历史事项的陈述。关于公司计划根据纳斯达克规则提交报告并重新符合要求、业绩、前景、收入及 Moolec 业务其他方面的前瞻性声明是基于当前期望和假设的预测、预测和其他关于未来事件的陈述，因此受到风险和不确定性的影响。尽管我们相信我们对本新闻稿中包含的每个前瞻性声明都有合理的依据，但我们提醒您，这些声明是基于一系列事实和因素，我们无法确定。我们不能保证本新闻稿中的前瞻性声明将被证明是准确的。这些前瞻性声明受到多种重大风险和不确定性的影响，这可能导致实际结果与预期结果有重大差异，包括但不限于适用法律或法规的变化、Moolec 可能受到经济、商业和/或其他竞争因素的不利影响、与 Moolec 业务扩展相关的成本以及其他风险和不确定性，包括在 Moolec 向美国证券交易委员会（&#34;SEC&#34;）提交的 20-F 年度报告中的&#34;风险因素&#34;标题下列出的风险，以及 Moolec 向 SEC 的其他提交。如果这些风险或不确定性中的一个或多个实现，或者我们的任何假设被证明不正确，实际结果可能在重大方面与这些前瞻性声明中预测的结果有所不同。我们没有义务更新或修订任何前瞻性声明，无论是由于新信息、未来事件还是其他原因，除非适用证券法律要求。因此，您不应对这些声明过于依赖。</p>
<p>联系方式：ir@moolecscience.com（电话：+5493412034927）</p>
<p><strong>来源：</strong> Moolec Science</p>
<p>查看原始新闻稿，请访问 ACCESS Newswire</p>
<p><img src="https://imageproxy.pbkrs.com/https://app.accessnewswire.com/img.ashx/query-aWQ9MTEyMjg4Nw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://app.accessnewswire.com/img.ashx/query-aWQ9MTEyMjg4Nw"/></p>

MLEC

<p>Moolec Science SA 收到了纳斯达克的通知函，指出其未符合 250 万美元的最低股东权益要求。该公司预计通过在破产后对某些子公司的去确认所带来的约 1.058 亿美元的收益来恢复合规。这一收益预计将产生正的净收入，满足纳斯达克 50 万美元的净收入要求。Moolec 专注于创新蛋白质解决方案，并在纳斯达克上市，股票代码为 "MLEC"</p>

<p>Moolec Science SA (&#34;Moolec&#34; or the &#34;Company&#34;) received an additional determination letter (the &#34;Letter&#34;) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (&#34;Nasdaq&#34;) indicating that the Company does not currently meet the minimum stockholders' equity requirement of $2.5 million under Nasdaq Listing Rule 5550(b)(1).</p>
<div class="lb-trans"><p>Moolec Science SA（&#34;Moolec&#34;或&#34;公司&#34;）收到了纳斯达克证券市场有限责任公司（&#34;纳斯达克&#34;）上市资格部门的额外决定函（&#34;函件&#34;），指出公司目前未满足纳斯达克上市规则 5550(b)(1) 下 250 万美元的最低股东权益要求。</p>
</div><p>As previously disclosed in the Company's Form 20-F for the year ended June 30, 2025, management expects to regain compliance with the Nasdaq continued listing standards through the recognition of an estimated gain of approximately $105.8 million related to the derecognition of certain subsidiaries following their bankruptcy proceedings. Upon completion of this accounting process, the Company anticipates that the gain resulting from this accounting process will generate a positive net income, enabling the Company to satisfy Nasdaq's net income standard requirement of $500,000.</p>
<div class="lb-trans"><p>正如公司在截至 2025 年 6 月 30 日的 20-F 表格中所披露的，管理层预计通过确认与某些子公司破产程序相关的约 1.058 亿美元的预估收益，重新符合纳斯达克持续上市标准。在完成这一会计过程后，公司预计该会计过程产生的收益将产生正的净收入，使公司能够满足纳斯达克 50 万美元的净收入标准要求。</p>
</div><p>The derecognition process is already underway following the bankruptcy filing of certain subsidiaries.</p>
<div class="lb-trans"><p>在某些子公司申请破产后，去确认过程已经开始。</p>
</div><p>This disclosure is made in accordance with Nasdaq Listing Rule 5810(b), which requires prompt public announcement upon receipt of a notification of non-compliance.</p>
<div class="lb-trans"><p>此披露是根据纳斯达克上市规则 5810(b) 进行的，该规则要求在收到不合规通知后及时进行公开公告。</p>
</div><p><strong>About Moolec Science SA</strong></p>
<div class="lb-trans"><p><strong>关于 Moolec Science SA</strong></p>
</div><p>Moolec Science is an innovation-driven company engineering plants and microbes to unlock scalable protein solutions for the global food system. By integrating Molecular Farming and precision fermentation, Moolec combines the cost efficiency of crops with the functionality and nutrition of animal proteins, creating sustainable and commercially viable ingredients. The Company's diversified pipeline includes alternative proteins, bioactive compounds, nutritional oils, and biological inputs for regenerative agriculture. Moolec has a robust intellectual property portfolio with more than 118 granted and pending patents across multiple technology platforms. With operations spanning the United States, Europe and South America, Moolec is advancing a seed-to-ingredient approach designed to transform the future of food production. Moolec is publicly listed on Nasdaq under the ticker &#34;MLEC.&#34; For more information, please visit www.moolecscience.com and ir.moolecscience.com.</p>
<div class="lb-trans"><p>Moolec Science 是一家以创新为驱动的公司，致力于工程植物和微生物，以解锁全球食品系统的可扩展蛋白质解决方案。通过整合分子农业和精密发酵，Moolec 将作物的成本效益与动物蛋白的功能性和营养结合起来，创造可持续且商业上可行的成分。公司的多元化产品线包括替代蛋白质、生物活性化合物、营养油和用于再生农业的生物输入。Moolec 拥有强大的知识产权组合，在多个技术平台上拥有超过 118 项已授予和待审专利。Moolec 的业务遍及美国、欧洲和南美，正在推进一种从种子到成分的方式，旨在改变未来的食品生产。Moolec 在纳斯达克上市，股票代码为&#34;MLEC&#34;。有关更多信息，请访问 www.moolecscience.com 和 ir.moolecscience.com。</p>
</div><p><strong>Forward-looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press release contains &#34;forward-looking statements.&#34; Forward-looking statements may be identified by the use of words such as &#34;forecast,&#34; &#34;intend,&#34; &#34;seek,&#34; &#34;target,&#34; &#34;anticipate,&#34; &#34;believe,&#34; &#34;expect,&#34; &#34;estimate,&#34; &#34;plan,&#34; &#34;outlook,&#34; and &#34;project&#34; and other similar expressions that predict or indicate future events or trends or that are not statements of historical matters. Such forward-looking statements with respect to the Company's plan to file reports and regain compliance under the Nasdaq rules, performance, prospects, revenues, and other aspects of the business of Moolec are predictions, projections and other statements about future events that are based on current expectations and assumptions and, as a result, are subject to risks and uncertainties. Although we believe that we have a reasonable basis for each forward-looking statement contained in this press release, we caution you that these statements are based on a combination of facts and factors, about which we cannot be certain. We cannot assure you that the forward-looking statements in this press release will prove accurate. These forward-looking statements are subject to a number of significant risks and uncertainties that could cause actual results to differ materially from expected results, including, among others, changes in applicable laws or regulations, the possibility that Moolec may be adversely affected by economic, business and/or other competitive factors, costs related to the scaling up of Moolec's business and other risks and uncertainties, including those included under the header &#34;Risk Factors&#34; in Moolec's Annual Report on Form 20-F filed with the U.S. Securities and Exchange Commission (&#34;SEC&#34;), as well as Moolec's other filings with the SEC. Should one or more of these risks or uncertainties materialize, or should any of our assumptions prove incorrect, actual results may vary in material respects from those projected in these forward-looking statements. We undertake no obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required under applicable securities laws. Accordingly, you should not put undue reliance on these statements.</p>
<div class="lb-trans"><p>本新闻稿包含&#34;前瞻性声明&#34;。前瞻性声明可以通过使用诸如&#34;预测&#34;、&#34;打算&#34;、&#34;寻求&#34;、&#34;目标&#34;、&#34;预期&#34;、&#34;相信&#34;、&#34;期待&#34;、&#34;估计&#34;、&#34;计划&#34;、&#34;展望&#34;和&#34;项目&#34;等词语以及其他类似表达来识别，这些词语预测或指示未来事件或趋势，或不是历史事项的陈述。关于公司计划根据纳斯达克规则提交报告并重新符合要求、业绩、前景、收入及 Moolec 业务其他方面的前瞻性声明是基于当前期望和假设的预测、预测和其他关于未来事件的陈述，因此受到风险和不确定性的影响。尽管我们相信我们对本新闻稿中包含的每个前瞻性声明都有合理的依据，但我们提醒您，这些声明是基于一系列事实和因素，我们无法确定。我们不能保证本新闻稿中的前瞻性声明将被证明是准确的。这些前瞻性声明受到多种重大风险和不确定性的影响，这可能导致实际结果与预期结果有重大差异，包括但不限于适用法律或法规的变化、Moolec 可能受到经济、商业和/或其他竞争因素的不利影响、与 Moolec 业务扩展相关的成本以及其他风险和不确定性，包括在 Moolec 向美国证券交易委员会（&#34;SEC&#34;）提交的 20-F 年度报告中的&#34;风险因素&#34;标题下列出的风险，以及 Moolec 向 SEC 的其他提交。如果这些风险或不确定性中的一个或多个实现，或者我们的任何假设被证明不正确，实际结果可能在重大方面与这些前瞻性声明中预测的结果有所不同。我们没有义务更新或修订任何前瞻性声明，无论是由于新信息、未来事件还是其他原因，除非适用证券法律要求。因此，您不应对这些声明过于依赖。</p>
</div><p>Contact: ir@moolecscience.com (phone: +5493412034927)</p>
<div class="lb-trans"><p>联系方式：ir@moolecscience.com（电话：+5493412034927）</p>
</div><p><strong>SOURCE:</strong> Moolec Science</p>
<div class="lb-trans"><p><strong>来源：</strong> Moolec Science</p>
</div><p>View the original press release on ACCESS Newswire</p>
<div class="lb-trans"><p>查看原始新闻稿，请访问 ACCESS Newswire</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://app.accessnewswire.com/img.ashx/query-aWQ9MTEyMjg4Nw" alt="" original-src="https://app.accessnewswire.com/img.ashx?id=1122887"/></p>

Moolec 收到员工决定信，并更新其在纳斯达克上市的合规状态 | MLEC 股票新闻